High-frequency developmental abnormalities in p53-deficient miceJane F Armstrong, Alan R. Clarke, M. H. Kaufman et al.|Current Biology|1995Cited by 467
Systems Biology Reveals New Strategies for Personalizing Cancer Medicine and Confirms the Role of PTEN in Resistance to TrastuzumabDana Faratian, David J. Harrison|Cancer Research|2009Cited by 160
Effects of heterozygosity for the Rb-1t19neo allele in the mouse.David J. Harrison, Alan R. Clarke, Hooper Ml et al.|PubMed|1995Cited by 66
Quantification of tumour budding, lymphatic vessel density and invasion through image analysis in colorectal cancerPeter D. Caie, David J. Harrison|Journal of Translational Medicine|2014Cited by 53
The Novel Nucleoside Analogue ProTide NUC-7738 Overcomes Cancer Resistance Mechanisms <i>In Vitro</i> and in a First-In-Human Phase I Clinical TrialHagen Schwenzer, Sarah P. Blagden, Erica De Zan et al.|Clinical Cancer Research|2021Cited by 44